These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3304729)

  • 1. Experimental and clinical approaches to treatment of hypertension by dopamine receptor agonists.
    Montastruc JL; Chamontin B; Rostin M; Rascol O; Valet P; Gaillard G; Tran MA; Van TT; Ader JL; Montastruc P
    Clin Exp Hypertens A; 1987; 9(5-6):1069-84. PubMed ID: 3304729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the cardiovascular actions of apomorphine in dogs: central versus peripheral mechanisms and role of the adrenal medulla.
    Montastruc JL; Guiol C; Tran MA; Lhoste F; Montastruc P
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):92-103. PubMed ID: 4062436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study of the hypotensive effect of apomorphine].
    Montastruc JL; Guiol C
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1176-80. PubMed ID: 6441536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotensive action of bromocriptine in the DOCA-salt hypertensive rat: contribution of spinal dopamine receptors.
    Lahlou S; Duarte GP
    Fundam Clin Pharmacol; 1998; 12(6):599-606. PubMed ID: 9917201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine and apomorphine stimulation of cortisol secretion in conscious dogs; evidence for a stimulatory site located outside the blood brain barrier.
    Goiny M; Uvnäs-Moberg K; Cekan S
    Psychopharmacology (Berl); 1986; 89(1):108-12. PubMed ID: 3090584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution].
    Chamontin B; Montastruc JL; Rascol A
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1181-5. PubMed ID: 6151826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopaminergic drugs on plasma levels of steroid hormones in conscious dogs.
    Goiny M; Cekan S; Uvnäs-Moberg K
    Life Sci; 1986 Jun; 38(25):2293-300. PubMed ID: 3724358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypotensive action of a dopaminergic agonist, bromocriptine, in the dog].
    Montastruc JL; Rascol A; Montastruc P
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():91-8. PubMed ID: 6794532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.
    Damase-Michel C; Montastruc JL; Gharib C; Geelen G; De Saint-Blanquat G; Tran MA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):770-7. PubMed ID: 1968975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure effects of intravenous apomorphine in conscious deoxycorticosterone-acetate salt-hypertensive rats.
    Toscano CF; Lahlou S
    J Cardiovasc Pharmacol; 2003 Dec; 42(6):772-81. PubMed ID: 14639100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central dopaminergic origin of bromocriptine induced tachycardia in normotensive rats.
    Lahlou S; Duarte GP; Demenge P
    Cardiovasc Res; 1993 Nov; 27(11):2022-7. PubMed ID: 8287413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
    McCoy CE; Douglas FL; Goldberg LI
    Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
    Lahlou S
    Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the adrenal glands in the hypotensive response to bromocriptine in spontaneously hypertensive rats.
    Hamilton TC
    Br J Pharmacol; 1981 Mar; 72(3):419-25. PubMed ID: 6114765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive action of bromocriptine in neurogenic hypertensive dogs.
    Montastruc JL; Montastruc P
    Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):210-8. PubMed ID: 7305559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in the hypotensive effect of bromocriptine induced by spinal transection in rats: contribution of spinal dopamine receptors.
    Lahlou S; Demenge P
    J Cardiovasc Pharmacol; 1992 May; 19(5):723-31. PubMed ID: 1381770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine: pharmacologic and therapeutic aspects.
    Velasco M; Luchsinger A
    Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of spinal dopamine receptors to the hypotensive action of bromocriptine in rats.
    Lahlou S; Demenge P
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):317-25. PubMed ID: 1720830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of peripheral neuronal dopamine receptors in the rat.
    Dupont AG; Lefebvre RA; Bogaert MG
    Clin Exp Hypertens A; 1987; 9(5-6):913-29. PubMed ID: 2887314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.